Stereotaxis appoints Burkhardt from Cleveland Clinic as CMO
Stereotaxis has appointed J. David Burkhardt, MD, FACC, as chief medical officer (CMO).

Burkhardt was most recently the associate program director for the clinical cardiac electrophysiology fellowship training program and he directed the clinical electrophysiology curriculum at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic, according to the St. Louis-based Stereotaxis.

Burkhardt is board certified in internal medicine, cardiovascular medicine and clinical cardiac electrophysiology, the company said.